Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Ruminations about biotech and drug development - one overly earnest blog post at a time. Click to read Alex Kesin's Pharmacopoeia, a Substack publication with thousands of subscribers.
News
China has caught up in biotech. How screwed are we?
On July 19th, Yoni Ben-Shimon and I are hosting a half-day Bay Area retreat to dig into the ideas in this piece. We're bringing together biotech operators and policy people. If that's you, apply here.If you have successfully avoided Biotech Twitter recent
Read more
Report
Side Effects May Include Artificially Inflated EPS
Belshazzar's Feast (Rembrandt, c. 1635-1638)You wake one morning from uneasy dreams and find yourself transformed in your bed into the CEO of a mid-cap publicly traded pharmaceutical conglomerate. Stranger things have happened.There's no time to dwell on
Read more
Report
Pharma Is Hollywood, Roughly
Of all the new drugs introduced in the United States between 1988 and 1992, the top decile by revenue captured 56% of cumulative sales over the next eleven years. Of the 361 new therapeutic agents the FDA approved between 1995 and 2014, the 25 best-seller
Read more
Report
They Put a TB Vaccine Where?!
Every year, roughly 83,000 Americans are diagnosed with bladder cancer. Of those, about 70-75% have what's called non-muscle-invasive bladder cancer, or NMIBC -- meaning the tumor hasn't grown into the muscular wall of the bladder. It's still on the surfa
Read more
Report
Report
Pro access
Upgrade to see all 28 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
